DUBLIN--(BUSINESS WIRE)--The "Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
This infectious disease diagnostics market study presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product & solution, technology, disease type, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.
Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the in-depth analysis on key industry drivers, restraints, challenges, and opportunities. The growth in the infectious disease diagnostics market is mainly attributed to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, and Swine Flu, among others; growing awareness for early detection using specific diagnostic tests; growth in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized point-of-care testing services. Moreover, advances in genomics and proteomics and emerging countries provide increasing growth opportunities for players operating in the infectious disease diagnostics market.
An in-depth analysis of the geographical scenario of the infectious disease diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to command the largest share of the global infectious disease diagnostics market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
However, Asia Pacific region is slated to register the highest growth during the forecast period primarily due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.
- Increasing Prevalence of Infectious Diseases
- Growing Awareness of Early Disease Diagnosis
- Impact of COVID-19
- Rising Funds for Infectious Disease Diagnostics Research Activities
- Shift in Focus from Centralized Laboratories to POC Testing Services
- Unfavorable and Inadequate Reimbursement Scenario
- Advances in Genomics and Proteomics
- Growing Awareness About Personalized Medicine
- Emerging Economies
- Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections
- Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
- Danaher Corporation
- DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Meridian Bioscience Inc.
- Quidel Corporation
Thermo Fisher Scientific
- bioMrieux S.A.
For more information about this report visit https://www.researchandmarkets.com/r/p21nic